Cervix Cancer

Oncology
3
Pipeline Programs
5
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
2100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
PembrolizumabPhase 2Monoclonal Antibody1 trial
Active Trials
NCT06266338Recruiting30Est. Oct 2027
GS
Gilead SciencesFOSTER CITY, CA
2 programs
2
Artesunate pessaryPhase 11 trial
Artesunate pessaryPhase 1
Active Trials
NCT06165614Completed17Est. Apr 2025
Mauna Kea Technologies
1 program
Confocal Laser EndomicroscopyN/A1 trial
Active Trials
NCT02221076CompletedEst. Apr 2016
Bristol Myers Squibb
1 program
Nivolumab and IpilimumabN/AMonoclonal Antibody1 trial
Active Trials
NCT04256213Completed40Est. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Merck & Co.Pembrolizumab
Gilead SciencesArtesunate pessary
Bristol Myers SquibbNivolumab and Ipilimumab
Mauna Kea TechnologiesConfocal Laser Endomicroscopy

Clinical Trials (4)

Total enrollment: 87 patients across 4 trials

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

Start: Mar 2024Est. completion: Oct 202730 patients
Phase 2Recruiting
NCT06165614Gilead SciencesArtesunate pessary

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Start: Mar 2024Est. completion: Apr 202517 patients
Phase 1Completed
NCT04256213Bristol Myers SquibbNivolumab and Ipilimumab

COL Immunotherapy Before Radiochimio + Ipilimumab

Start: Jul 2020Est. completion: Aug 202440 patients
N/ACompleted
NCT02221076Mauna Kea TechnologiesConfocal Laser Endomicroscopy

Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.

Start: Jul 2014Est. completion: Apr 2016
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 87 patients
5 companies competing in this space